中国普通外科杂志2017，Vol.26Issue(11)：1466-1471,6.DOI:10.3978/j.issn.1005-6947.2017.11.015
结节性甲状腺肿术后促甲状腺激素抑制治疗研究进展
Research progress of thyroid-stimulating hormone suppressive therapy for nodular goiter after surgery
摘要
Abstract
Nodular goiter is a common disease in the field of general surgery, and has a high postoperative recurrence rate, which poses a challenge for following treatment. Nevertheless, standardized postoperative thyroxine treatment can effectively reduce postoperative recurrence of the nodular goiter by inhibiting the thyroid-stimulating hormone (TSH) of the patients and controlling it at a proper level after operation. Here, the authors address the progress of postoperative TSH suppressive therapy for nodular goiter patients.关键词
甲状腺肿,结节性/促甲状腺素/激素替代疗法/综述文献Key words
Goiter/Nodular/Thyrotropin/Hormone Replacement Therapy/Review分类
医药卫生引用本文复制引用
殷剑光..结节性甲状腺肿术后促甲状腺激素抑制治疗研究进展[J].中国普通外科杂志,2017,26(11):1466-1471,6.基金项目
国家自然科学基金资助项目(81172326) （81172326）
上海市慈善癌症研究基金资助项目. （）
